4
Changes in Ownership
Obsidian Therapeutics, Inc. Filed Acc 0001193125-26-335083
Options or other derivatives
- Director acquired 37,653 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Norkunas Matthew Director | 2026-08-03 | Grant or award · Stock Option (Right to Buy) | +37,653 | 37,653 | D | ||
Loading xslF345X06/ownership.xml…